BIOSPECIFICS TECHNOLOGIES CORP 4
4 · BIOSPECIFICS TECHNOLOGIES CORP · Filed Jun 25, 2015
Insider Transaction Report
Form 4
Gitman Paul
Director
Transactions
- Exercise/Conversion
Common Stock, $0.001 par value
2015-06-23$26.43/sh+15,000$396,450→ 73,133 total - Sale
Common Stock, $0.001 par value
2015-06-23$50.95/sh−15,000$764,310→ 51,825 total - Exercise/Conversion
Stock Option (Right to Buy)
2015-06-23−15,000→ 0 totalExercise: $20.00Exp: 2018-09-07→ Common Stock, $0.001 par value (15,000 underlying) - Exercise/Conversion
Common Stock, $0.001 par value
2015-06-23$13.60/sh+6,308$85,789→ 58,133 total - Sale
Common Stock, $0.001 par value
2015-06-23$53.59/sh−6,308$338,018→ 81,825 total - Exercise/Conversion
Common Stock, $0.001 par value
2015-06-23$20.00/sh+15,000$300,000→ 88,133 total - Sale
Common Stock, $0.001 par value
2015-06-23$51.84/sh−15,000$777,585→ 66,825 total - Exercise/Conversion
Stock Option (Right to Buy)
2015-06-23−15,000→ 0 totalExercise: $26.43Exp: 2019-09-07→ Common Stock, $0.001 par value (15,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2015-06-23−6,308→ 8,692 totalExercise: $13.60Exp: 2018-06-09→ Common Stock, $0.001 par value (6,308 underlying)
Footnotes (7)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 8, 2015.
- [F2]The selling price of $53.5856 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $53.00 to $56.04. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]The selling price of $51.8390 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $51.00 to $56.04. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]The selling price of $50.9540 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $49.00 to $56.04. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F5]The option was granted on June 10, 2008 and it was to vest monthly with respect to 1/12 of the total number of shares until all shares underlying the option have vested. All shares underlying the option have vested.
- [F6]The option was granted on September 8, 2009 and it was to vest monthly with respect to 1/12 of the total number of shares until all shares underlying the option have vested. All shares underlying the option have vested.
- [F7]The option was granted on September 8, 2008 and it was to vest monthly with respect to 1/12 of the total number of shares until all shares underlying the option have vested. All shares underlying the option have vested.